Posted by Paul_d_234 on September 29, 2004, at 20:05:32
In reply to Re: Cymbalta, posted by hawkeye on September 28, 2004, at 17:55:58
I'm doing fine on it (See Zoloft to Cymbalta) on this board for my journal.
Others are benefiting and some are not - pretty typical of most ADs - individual benefits will vary.
"EU Scientific Committee recommends approval of Cymbalta® and Xeristar® for treatment of major depressive episodes
> 17 Sep 2004
>
> Eli Lilly and Company and Boehringer Ingelheim today announced that the Committee for Medicinal Products in Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of duloxetine for the treatment of major depressive episodes. The CHMP has recommended that the European Commission authorize the drug to be marketed. If approved, this pharmaceutical treatment for depression will be marketed throughout the European Union by Lilly under the brand name Cymbalta® and by Boehringer Ingelheim under the brand names Cymbalta and, in Greece, Italy and Spain, as Xeristar®.
>
> The European Commission is expected to grant marketing authorization within the next few months. Duloxetine for major depressive disorder was recently approved by the U.S. Food and Drug Administration and launched in the United States."
>
> http://www.medicalnewstoday.com/medicalnews.php?newsid=13575#
>
poster:Paul_d_234
thread:396440
URL: http://www.dr-bob.org/babble/20040927/msgs/397001.html